A detailed history of Central Trust CO transactions in Boston Scientific Corp stock. As of the latest transaction made, Central Trust CO holds 5,518 shares of BSX stock, worth $490,826. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,518
Previous 6,067 9.05%
Holding current value
$490,826
Previous $467,000 1.07%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$72.96 - $84.0 $40,055 - $46,116
-549 Reduced 9.05%
5,518 $462,000
Q2 2024

Aug 05, 2024

SELL
$67.33 - $77.71 $10,099 - $11,656
-150 Reduced 2.41%
6,067 $467,000
Q1 2024

Apr 24, 2024

SELL
$57.6 - $68.62 $15,264 - $18,184
-265 Reduced 4.09%
6,217 $425,000
Q4 2023

Jan 24, 2024

SELL
$48.64 - $57.81 $26,022 - $30,928
-535 Reduced 7.62%
6,482 $374,000
Q3 2023

Oct 26, 2023

SELL
$50.19 - $54.68 $84,319 - $91,862
-1,680 Reduced 19.32%
7,017 $370,000
Q2 2023

Jul 26, 2023

SELL
$49.72 - $54.64 $8,452 - $9,288
-170 Reduced 1.92%
8,697 $470,000
Q1 2023

Apr 19, 2023

BUY
$45.09 - $50.03 $5,636 - $6,253
125 Added 1.43%
8,867 $443,000
Q4 2022

Jan 26, 2023

SELL
$39.56 - $47.22 $4,747 - $5,666
-120 Reduced 1.35%
8,742 $0
Q3 2022

Nov 17, 2022

BUY
$36.71 - $109.66 $11,380 - $33,994
310 Added 3.62%
8,862 $343,000
Q2 2022

Aug 09, 2022

BUY
$35.24 - $47.1 $277,162 - $370,441
7,865 Added 1144.83%
8,552 $319,000
Q2 2020

Jul 14, 2020

SELL
$30.19 - $39.11 $18,114 - $23,466
-600 Reduced 46.62%
687 $24,000
Q1 2020

Apr 17, 2020

BUY
$25.83 - $45.71 $12,915 - $22,855
500 Added 63.53%
1,287 $41,000
Q1 2018

Apr 04, 2018

BUY
$25.2 - $28.54 $17,312 - $19,606
687 Added 687.0%
787 $0
Q4 2017

Jan 23, 2018

SELL
$24.79 - $29.8 $30,863 - $37,101
-1,245 Reduced 92.57%
100 $0
Q3 2017

Oct 17, 2017

BUY
$26.26 - $29.17 $35,319 - $39,233
1,345
1,345 $0

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $127B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Central Trust CO Portfolio

Follow Central Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.